Clinical Trials Directory

Trials / Sponsors / Kunming Pharmaceuticals, Inc.

Kunming Pharmaceuticals, Inc.

Industry · 8 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Inject
Delirium
Phase 12026-03-01
RecruitingEfficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Acute Ischemic Stroke
Phase 22025-11-22
Not Yet RecruitingA Trial to Evaluate KPC000154 Tablets in Healthy Subjects
Healthy Subjects、Lipid Metabolism
Phase 12025-03-07
UnknownStudy of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke
Acute Ischemic Stroke
Phase 22023-03-01
UnknownSafety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid
Advanced Solid Tumor
Phase 12021-07-31
UnknownComparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults.
Healthy
Phase 12021-02-22
UnknownSafety,Tolerability, and Pharmacokinetic of KPCXM18 for Injection
Healthy
Phase 12020-11-01
UnknownExploratory Study of DHA in Systemic Lupus Erythematosus Patients
Systemic Lupus Erythematosus
Phase 22018-03-01